Find research datasets worth reusing

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

ClinicalTrials.gov study NCT02069717. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a R

ClinicalTrials.gov study NCT03160040. IPD Sharing: NO. Countries: 1. Publications: 0.

Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals

ClinicalTrials.gov study NCT02044718. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML)

ClinicalTrials.gov study NCT05144243. IPD Sharing: YES. Countries: 1. Publications: 0.

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics (BIPass II)

ClinicalTrials.gov study NCT05550805. IPD Sharing: NO. Countries: 1. Publications: 0.

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

ClinicalTrials.gov study NCT03292666. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) In

ClinicalTrials.gov study NCT06032546. IPD Sharing: YES. Countries: 13. Publications: 0.

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

ClinicalTrials.gov study NCT06846320. IPD Sharing: YES. Countries: 2. Publications: 0.

Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery.

ClinicalTrials.gov study NCT05387694. IPD Sharing: Not stated. Countries: 1. Publications: 0.

The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).

ClinicalTrials.gov study NCT06106711. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

ClinicalTrials.gov study NCT04813263. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

ClinicalTrials.gov study NCT06257875. IPD Sharing: YES. Countries: 30. Publications: 0.

Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

ClinicalTrials.gov study NCT05956509. IPD Sharing: YES. Countries: 1. Publications: 0.

Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

ClinicalTrials.gov study NCT06806293. IPD Sharing: YES. Countries: 12. Publications: 0.

NICSO National Study: Physician - Nurse Monitoring Project About Oncological Adverse Events

ClinicalTrials.gov study NCT04726020. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

ClinicalTrials.gov study NCT05548062. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov study NCT05650632. IPD Sharing: NO. Countries: 7. Publications: 0.

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination

ClinicalTrials.gov study NCT06892522. IPD Sharing: YES. Countries: 5. Publications: 0.

A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult

ClinicalTrials.gov study NCT06673238. IPD Sharing: NO. Countries: 1. Publications: 0.

Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies

ClinicalTrials.gov study NCT03436381. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.